Navigation Links
Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
Date:4/29/2008

tle lupus with their families every day have waited long enough."

About Lupus

Lupus is the result of an unbalanced immune system that can become destructive to any major organ or tissue in the body. Lupus is unpredictable and potentially fatal, yet no satisfactory treatment or cure exists. Its health consequences may include heart attacks, strokes, seizures, or sudden organ failure. Current treatments are immune-suppressing agents, which have toxic side effects, increasing risks for infections and other bodily damage. The LFA estimates that more than 1.5 million Americans have some form of lupus.

Although lupus can strike any person at any age, nine of 10 people with lupus are women of childbearing age (ages 15-45). Lupus is two to three times more common among women of color, including African Americans, Hispanics, Native Americans and Asians.

About the Lupus Foundation of America

The LFA is the nation's foremost nonprofit voluntary health organization dedicated to finding the causes of and cure for lupus, and providing support, services, and hope to all people affected by lupus. The LFA and its network of nearly 300 chapters, branches, and support groups conduct programs of research, education, and advocacy.


'/>"/>
SOURCE Lupus Foundation of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
2. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
3. Media Statement: MHA Keystone Center for Patient Safety & Quality OHRP Ruling
4. Statement from the American Diabetes Association Related to ACCORD Trial Announcement
5. Statement of Andrea Kavanagh, Director, Pure Salmon Campaign, on the Science Sea Lice Study
6. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
8. Statement From The National Conclave on HIV/AIDS Policy for Black Clergy
9. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
10. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
11. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 ... clinical research unit with a worldwide reputation for ... its frequent publications in peer reviewed medical journals. ... stakeholders and regulators in discussions about rules for ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical ...
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... (Ankle Replacement, Digit Replacement, Elbow Replacement, Hip ... to 2019" report to their offering. ... knee replacement was valued at $4,470.9 million ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 ... has announced the addition of the "Market ... and Europe" report to their offering. ,     ... analysis of the respiratory imaging diagnostics market in ... Europe . The service provides ...
Breaking Medicine Technology:North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2United States and Europe Respiratory Diagnostics Market Assessment 2015 2
... 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... devices worldwide, announced today its selected unaudited financial results for ... Highlights for Second Quarter 2011 ... 21.2% over the second quarter of 2010. Robust ...
... Pharmaceutical Company ("the Company," "K-V") (NYSE: KVa/KVb) today announced ... of assets of Nesher Pharmaceuticals, Inc. ("Nesher"), the Company,s ... assets to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals ... sales price for the transaction is $60 million (subject ...
Cached Medicine Technology:Mindray Announces Second Quarter 2011 Financial Results 2Mindray Announces Second Quarter 2011 Financial Results 3Mindray Announces Second Quarter 2011 Financial Results 4Mindray Announces Second Quarter 2011 Financial Results 5Mindray Announces Second Quarter 2011 Financial Results 6Mindray Announces Second Quarter 2011 Financial Results 7Mindray Announces Second Quarter 2011 Financial Results 8Mindray Announces Second Quarter 2011 Financial Results 9Mindray Announces Second Quarter 2011 Financial Results 10Mindray Announces Second Quarter 2011 Financial Results 11Mindray Announces Second Quarter 2011 Financial Results 12Mindray Announces Second Quarter 2011 Financial Results 13Mindray Announces Second Quarter 2011 Financial Results 14Mindray Announces Second Quarter 2011 Financial Results 15Mindray Announces Second Quarter 2011 Financial Results 16Mindray Announces Second Quarter 2011 Financial Results 17K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 2K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 3K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 4K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 5K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 6K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 7K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 8
(Date:5/24/2015)... York (PRWEB) May 24, 2015 ... lawsuits ( http://www.testosteronelawsuithub.com/ ) has scheduled its next ... of the multidistrict litigation. According to court documents ... of Illinois, the Conference will be convened on ... Testosterone Replacement Therapy Product Liability Litigation - MDL ...
(Date:5/24/2015)... Scottsdale, Arizona (PRWEB) May 24, 2015 ... hired former Millennial Media strategy executive Jay Krihak ... as Medicx looks to ramp up its expertise ... services of the Pharmaceutical and Health sectors. , ... ad tech executive. Most recently, Krihak led sales ...
(Date:5/23/2015)... 2015 On Saturday, May 23, 2015, over ... for Branches Florida City exactly five years to the day ... 2010. , A large fire tore through the Branches United ... 2010 in the middle of the night as neighbors, staff ... declared arson even though it is suspected that the fire ...
(Date:5/23/2015)... 23, 2015 With the implementation of ... finding it increasingly difficult to provide their employees with ... provide adequate insurance for employees stand to face strict ... an integral part of a business’s success or failure. ... businesses, Online USA Doctors has created a varying level ...
(Date:5/23/2015)... Manufacturers are now required to produce water heaters ... Experts in the field agree that the regulation is aimed ... score is what miles per gallon is to your car. ... the minimum HSPF score has been raised to 8.2, technology ... north of 12. Indeed, the regulation was welcomed by environmentalist, ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Medicx Media Solutions Expands Executive Team 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2
... November 6 - Elsevier Signs Agreement ... that major global healthcare company, Bayer,HealthCare AG, headquartered ... EMBASE Classic. Available in electronic format for,the first ... database,drawn from 43 Excerpta Medica Abstract Journals published ...
... book geared to genetic blueprints from Elite Books, TUCSON, ... gene. It,plays a key role in the development of Alzheimer,s ... And it is greatly affected,by diet. In her seminal ... Weight, Heart and Alzheimer,s Using the Body,s Own Genes,(Elite, Hardcover, ...
... Former Congressman,Henry J. Hyde was among eight people ... the Presidential Medal of Freedom. President Bush said,that ... of Mr. Hyde,s 32 years,of public service., ... Rehabilitation,Hospital where he is currently receiving medical rehabilitation ...
... 5 Epeius Biotechnologies,Corporation announced today that the company ... lead product with the opening of a Phase II,Registration ... the accelerated approval of Rexin-G for the treatment of ... in the Philippines, Epeius,opened a number of Phase I/II ...
... QED International Associates Inc,administrator for the HealthShares(TM) ... today announced that effective at the,opening of trading ... BSMD ) will replace Kyphon INC. (Nasdaq: ... The Corin Group (LSE: CRG.L) will,replace KYPH in ...
... 5 Hooper Holmes,Inc. (AMEX: HH ) today announced ... Inc. (Nasdaq: NABI ), has been,reappointed to the Company,s ... Board from 2005 to 2006. He replaces Paul Kolacki who,retired ... respect Les, and we are pleased to welcome him back ...
Cached Medicine News:Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 2Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 3Health News:Groundbreaking Apo E Gene Diet Linked to Alzheimer's Disease and Heart Disease Prevention 2Health News:Former Congressman Hyde Awarded Presidential Medal of Freedom While Receiving Medical Rehabilitation at Marianjoy 2Health News:FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A. 2Health News:FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A. 3Health News:QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes 2Health News:QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes 3Health News:Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors 2Health News:Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors 3
... temporary internal drainage from the ureteropelvic junction ... stricture. The segment with no sideports prevents ... preventing ingrowth of the ureteral wall to ... Intended for one-time use. CAUTION: Periodic evaluation ...
Since first designed by Dr. Roy P. Finney in 1978, ACMI™ Classic Ureteral Stents remain the standard for comfort, performance, and quality....
... retrograde or antegrade ureteral ... stent placement. The RB ... band on the delivery ... fluoroscopic visualization during placement. ...
... Used for interoperative placement to ... conduit construction and continent urinary ... packages. Intended for one-time use. ... stent must not remain indwelling ...
Medicine Products: